TRENDING: Dancing Elephant Stomps The Magnificent 7Â Penumbra (PEN) stock skyrocketed Thursday, coming within striking distance of a breakout, after the medtech company beat third-quarter expectations on the back of its blood-clot-removing tech. The company notched "another impressive quarter" for its venous thromboembolism, or VTE, platform in the U.S. where sales soared 34%. This technology helps doctors remove blood clots that form in veins, typically in the deep veins of the legs or in the lungs. Promis ...